Stanozolol

司坦唑醇

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameStanozolol
Drug Alias Name司坦药醇StanazolEstanozolol吡唑甲基睾丸素羟甲雄烷吡唑 +[13] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsWounds and InjuriesMalnutritionAngioedemas, Hereditary +[5] 
Global Approved IndicationsWounds and InjuriesMalnutritionAngioedemas, Hereditary +[5] 
Approved Indications in ChinaWounds and InjuriesMalnutritionAngioedemas, Hereditary
Original Approved Country/TerritoryUnited States
Original Approved Date1962/01/09
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesBestway Pharmaceutical Co Ltd
Inactive CompaniesLundbeck Inc
Active IndicationsWounds and InjuriesMalnutritionAngioedemas, Hereditary
Inactive IndicationsOsteoporosisBreast Neoplasms

Other Information

ATC CodeA14AA02
Related LinksWikipediaDrugBankKEGG